Molecular Assemblies President and CEO to Present at Second Silicon Valley Business Forum

Event to focus on building bridges between Korea and Silicon Valley with a Sustainability Initiative on companies advancing new technologies posed for exponential growth

SAN DIEGO, December 4, 2020 — Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced a presentation by the company’s President and CEO Michael J. Kamdar at the Second Silicon Valley Business Forum. The virtual event will take place December 9-11 and focus on building bridges between Korea and Silicon Valley. The aim for the event is to highlight organizations creating and delivering successful and sustainable enterprises of the future. The agenda highlights companies poised for exponential growth, and leaders whose unwavering focus is on fundamental technological breakthroughs.

Presentation Info:

  • Event: Second Silicon Valley Business Forum
  • Title: Solving the Challenges of DNA Synthesis 
  • Day: December 8
  • Time: 4:25 pm-4:40 pm PST

To register for the presentation on December 8 (Day 1 Healthcare), click here.

About the Silicon Valley Business Forum

Silicon Valley leaders and Korean entrepreneurs, venture capitalist, and innovators launched the Silicon Valley Business Forum to jointly address the challenges and opportunities in a post-COVID global environment. These private, invitation-only events facilitate conversations, collaborations and ongoing learnings that will not only be impactful but provide the impetus for how organizations can create resilient, scalable, and sustainable solutions. The inaugural Silicon Valley Business Forum that took place in September 2020 showcased 30 sessions, 33 guest speakers and had more than 800 attendees registered for the three-day event. For more information, please visit  

About Molecular Assemblies

Molecular Assemblies, Inc. is a private biotech company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented enzymatic method, based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. Molecular Assemblies’ technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. Molecular Assemblies is headquartered in San Diego.

Media Contact:

Jessica Yingling, Ph.D., Little Dog Communications Inc.,,